Introduction Minimally invasive esophagectomy (MIE) and robot-assisted MIE (RAMIE) are standard approaches in the treatment of Esophageal cancer. One debated step during surgery is whether to perform pyloroplasty, a procedure intended to improve gastric emptying after esophageal resection.
Introduction
Minimally invasive esophagectomy (MIE) and robot-assisted MIE (RAMIE) are standard approaches in the treatment of Esophageal cancer. One debated step during surgery is whether to perform pyloroplasty, a procedure intended to improve gastric emptying after esophageal resection. Despite widespread use, high-quality evidence supporting or refuting its benefit has been limited, especially in the modern minimally invasive era.
Problem Statement
There is a lack of level-1 evidence to determine whether adding pyloroplasty during MIE or RAMIE improves postoperative outcomes.
Summary
This phase III randomized controlled trial provides important evidence supporting the use of pyloroplasty during minimally invasive esophagectomy. The study used an adaptive design and demonstrated that patients undergoing pyloroplasty had better short-term outcomes compared to those without it.
The primary composite outcome—pneumonia or anastomotic leak requiring surgery—occurred less frequently in the pyloroplasty group (18%) compared to the no-pyloroplasty group (27%). The trial was stopped early once predefined superiority criteria were met, indicating a high probability that pyloroplasty improves short-term outcomes.
Clinically, this suggests that pyloroplasty may reduce postoperative complications, particularly respiratory and anastomotic issues, in patients undergoing MIE or RAMIE. However, long-term outcomes and quality-of-life data are still awaited.
Key takeaway: Adding pyloroplasty during minimally invasive esophagectomy improves short-term surgical outcomes and may be considered a beneficial adjunct procedure.
Introduction: Chronic postoperative inguinal pain (CPIP) remains one of the most important long-term complications after laparoscopic groin hernia repair, despite lower rates than with open surgery. Whether different mesh types and fixation methods influence the...
Introduction: Venous involvement is common in locally advanced pancreatic cancer and often necessitates superior mesenteric-portal vein resection with reconstruction during pancreaticoduodenectomy. However, reconstruction may not always be feasible because of extensive venous disease or unfavorable...
Introduction: Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy...
Introduction: Surgery is an inherently high-stress profession, where complications, patient deaths, and difficult decisions can lead to burnout, moral injury, and mental health disorders. Inspired by the US Marine Corps' Combat and Operational Stress Control...
Introduction: As surgical techniques and perioperative therapies have advanced, vascular resection during pancreatic cancer surgery has become increasingly common in selected patients with locally advanced disease. This study evaluated the long-term outcomes of venous and...
Introduction: Optimal drain management after pancreatoduodenectomy (PD) remains critical for preventing postoperative pancreatic fistula (POPF) while supporting enhanced recovery. This study proposes a dynamic, risk-adapted algorithm based on intraoperative risk and postoperative biochemical markers. Why...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.